From Paula's Desk: The Frontier of Managed Care Pharmacy Research Begins at Nexus 2021
Originally published in August 2021 AMCP Foundation Insights e-newsletter.
Dear #AMCPFdn Friends,
We will surface critical insights at AMCP Nexus 2021 this fall! Two upcoming events are themed upon the managed care pharmacy research agenda, a focal point in our organizational strategy.
Advancing a Real-World Evidence Managed Care Research Agenda is a CE session which will be held Wednesday, Oct. 20 at 2:45pm MT. The faculty are AMCP/Foundation Joint Research Committee Chair Joe Couto, AMCP 2020-21 Scholar-in-Residence Diana Brixner, and AMCP Board member Christina Barrington. We will discuss the real-world evidence pillar within the research agenda, especially the impact of FDA expedited approval processes and the role managed care professionals can play in addressing health disparities through their work. Case studies will provide real-life examples of how this important research pillar can be implemented into practice.
We’ll also discuss our new research aims at a poster presentation, “Advancing the Managed Care Pharmacy Research Agenda through Generation of RWE for Expedited FDA Approvals and Health Disparities,” on Wednesday, Oct. 20 at noon MT. This study was selected for a JMCP Silver Ribbon, a distinction extended to only 20% of the submitted abstracts. Each abstract was assessed by reviewers on the following five criteria: relevance, originality, quality, bias, and clarity.
We will also host opportunities to weigh in on implementation models to further advance the agenda. A core concept is to launch AMCP Foundation research agenda grants to fund collaborative teams interested in investigating our specified research aims. We are interested in doing so through two funding mechanisms.
- Targeted funds: Investing as lead sponsor of one research aim with $75,000-$100,000+. Collaborators at this level can review proposals submitted from managed care research teams, serve on work group, and/or partner on executing research if interested.
- Shared funds: Investing as a sponsor with $25,000-$75,000, applied to a single research aim or to the initiative in general. Collaborators at this level are not eligible to participate in selecting studies or executing research.
Of course, you don’t have to wait ‘til Nexus 2021 to share. Let me know your thoughts and get involved!
Gratefully and hopefully,
Paula J. Eichenbrenner, MBA, CAE
Executive Director, AMCP Foundation
P.S. Don’t miss the full line-up of AMCP Foundation’s research programming at Nexus 2021! Attend our research symposium and support the AMCP Foundation interns who will present their capstone research projects in the poster hall.